Study identifier:NIS-RCN-SYM-2006/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
A 3-month Non-interventional Study of Asthmatics Treatment with Symbicort® Turbuhaler®
asthma
-
No
-
All
310
Observational
6 Years +
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Jun 2009 by AstraZeneca Pharmaceuticals
AstraZeneca Pharmaceuticals
-
The purpose of this study is to investigate real practices of treatment with Symbicort Turbuhaler for 3 months in asthma and patient compliance.
Location
Location
Shanghai, China
Location
Wuhan, Hubei, China
Location
Xi'an, Shanxi, China
Location
Taiyuan, Shanxi, China
Location
Guangzhou, Guangdong, China
Location
Chongqing, China
Location
Shenzhen, Guangdong, China
Location
Suzhou, Jiangsu, China
Arms | Assigned Interventions |
---|---|
1 Chinese asthma patient prescribed Symbicort® Turbuhaler® | - |
This information is not intended to replace the informed medical advice or medical treatments of a healthcare professional. Only a physician can determine if a specific medicine is the correct treatment for a particular patient. If you have questions regarding any information contained in this site, you must consult a suitably qualified healthcare professional. Before prescribing any AstraZeneca products, Healthcare Professionals should view their country specific information.